Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (261-270 of 361) with videos related to

Pageof 37
Sort By:
Acta Haematologica|January 5, 2023
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaCharles Guisnel, Luciane Schirmer, Stéphane Morisset, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
Leukemia|December 22, 2018
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemiaJohannes Schetelig, Liesbeth C de Wreede, Michel van Gelder, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemiaOliver A Cornely, Thibaut Leguay, Johan Maertens, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 19, 2015
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatusPaul E Verweij, Michelle Ananda-Rajah, David Andes, et al.
The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.
Mycoses|February 4, 2020
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM surveyFanny Lanternier, Danila Seidel, Livio Pagano, et al.
Bone Marrow Transplantation|January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMTJuan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Blood|July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPARichard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.
Transplantation and Cellular Therapy|April 15, 2024
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationDina Averbuch, Gloria Tridello, Lotus Wendel, et al.
Pageof 37

Showing results (261-270 of 361) with videos related to

Sort By:
Pageof 37
Acta Haematologica|January 5, 2023
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaCharles Guisnel, Luciane Schirmer, Stéphane Morisset, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal diseaseOliver A Cornely, Michael N Robertson, Shariq Haider, et al.
Leukemia|December 22, 2018
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemiaJohannes Schetelig, Liesbeth C de Wreede, Michel van Gelder, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemiaOliver A Cornely, Thibaut Leguay, Johan Maertens, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 19, 2015
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatusPaul E Verweij, Michelle Ananda-Rajah, David Andes, et al.
The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.
Mycoses|February 4, 2020
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM surveyFanny Lanternier, Danila Seidel, Livio Pagano, et al.
Bone Marrow Transplantation|January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMTJuan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Blood|July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPARichard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.
Transplantation and Cellular Therapy|April 15, 2024
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationDina Averbuch, Gloria Tridello, Lotus Wendel, et al.
Pageof 37